Cargando…
Synergy of Phospholipid—Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells
The pivotal role of hepatic stellate cells (HSCs) in orchestrating the bidirectional process of progression and regression of liver fibrosis makes them an ideal target for exploring new antifibrotic therapies. Essential phospholipids (EPLs), with their polyenylphosphatidylcholine (PPC) fraction, eit...
Autores principales: | Valentino, Gina, Zivko, Cristina, Weber, Florian, Brülisauer, Lorine, Luciani, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969915/ https://www.ncbi.nlm.nih.gov/pubmed/31842373 http://dx.doi.org/10.3390/pharmaceutics11120676 |
Ejemplares similares
-
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators
por: Pastore, Mirella, et al.
Publicado: (2022) -
The Expression of HIV-1 Vpu in Monocytes Causes Increased Secretion of TGF-β that Activates Profibrogenic Genes in Hepatic Stellate Cells
por: Patel, Paresh, et al.
Publicado: (2014) -
Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4
por: Huang, Ying-Hsien, et al.
Publicado: (2015) -
HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells
por: Shi, Lei, et al.
Publicado: (2016) -
GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells
por: Arroyo, Noelia, et al.
Publicado: (2021)